Evidence map›Paper›PMID 33655271›Full record

ArticlemedRxiv : the preprint server for health sciences2021

Racial and ethnic differences in COVID-19 vaccine hesitancy and uptake.

Long H Nguyen, Amit D Joshi, David A Drew, Jordi Merino, Wenjie Ma, Chun-Han Lo, Sohee Kwon, Kai Wang, Mark S Graham, Lorenzo Polidori and 15 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 136 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 7 institutions in 3 countries.

Long H NguyenClinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Amit D JoshiClinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
David A DrewClinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Jordi MerinoDiabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Wenjie MaClinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Chun-Han LoClinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Sohee KwonClinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Kai WangClinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Mark S GrahamSchool of Biomedical Engineering & Imaging Sciences, King's College London. London, U.K.
Lorenzo PolidoriZoe Global Ltd, London, U.K.
Cristina MenniDepartment of Twin Research and Genetic Epidemiology, King's College London, London, U.K.
Carole H SudreSchool of Biomedical Engineering & Imaging Sciences, King's College London. London, U.K.
Adjoa Anyane-YeboaDivision of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Christina M AstleyBroad Institute of MIT and Harvard. Cambridge, MA, USA.
Erica T WarnerClinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Christina Y HuZoe Global Ltd, London, U.K.
Somesh SelvachandranZoe Global Ltd, London, U.K.
Richard DaviesZoe Global Ltd, London, U.K.
Denis NashInstitute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, NY, USA.
Paul W FranksDepartment of Clinical Sciences, Lund University, Malmö, Sweden.
Jonathan WolfZoe Global Ltd, London, U.K.
Sebastien OurselinSchool of Biomedical Engineering & Imaging Sciences, King's College London. London, U.K.
Claire J StevesDepartment of Twin Research and Genetic Epidemiology, King's College London, London, U.K.
Tim D SpectorDepartment of Twin Research and Genetic Epidemiology, King's College London, London, U.K.
Andrew T ChanClinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Harvard University · USKing's College London · GBZOE (United Kingdom) · GBBroad Institute · USCenter for Disease Dynamics, Economics & Policy · USCity University of New York · USLund University · SE

Funding

Dietary strategies for rational manipulation of the gut microbiome in inflammatory bowel diseaseK23DK125838 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI NGUYEN, LONG H · 2020 to 2024
$1.0M
Impact of Aspirin on the Gut Microbiome and Mucosal MicroenvironmentK01DK120742 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI DREW, DAVID A · 2020 to 2024
$793k
NIDDK NIH HHS K01 DK120742NIDDK NIH HHS K23 DK125838
6 · The paper itself

Abstract

backgroundRacial and ethnic minorities have been disproportionately impacted by COVID-19. In the initial phase of population-based vaccination in the United States (U.S.) and United Kingdom (U.K.), vaccine hesitancy and limited access may result in disparities in uptake.

methodsWe performed a cohort study among U.S. and U.K. participants in the smartphone-based COVID Symptom Study (March 24, 2020-February 16, 2021). We used logistic regression to estimate odds ratios (ORs) of COVID-19 vaccine hesitancy (unsure/not willing) and receipt.

resultsIn the U.S. (

conclusionsCOVID-19 vaccine hesitancy was greater among racial and ethnic minorities, and Black participants living in the U.S. were less likely to receive a vaccine than White participants. Lower uptake among Black participants in the U.S. during the initial vaccine rollout is attributable to both hesitancy and disparities in access.

Identifiers

PMID33655271
PMCPMC7924296
OpenAlexW3133616762

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.